Chronic hepatitis C in patients co-infected with human immunodeficiency virus in Japan: A retrospective multicenter analysis

Hepatology Research

Volumn 39, Issue 7, 2009, Pages 657-663

  Yotsuyanagi, Hiroshi ^a   Kikuchi, Yoshimi ^b   Tsukada, Kunihisa ^a,b   Nishida, Kyouji ^c   Kato, Michio ^d   Sakai, Hironori ^e   Takamatsu, Junki ^f   Hige, Shuhei ^g   Chayama, Kazuaki ^h   Moriya, Kyoji ^a   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

^d OSAKA NATIONAL HOSPITAL   (Japan)

^e KYUSHU CENTRAL HOSPITAL   (Japan)

^f NAGOYA UNIVERSITY HOSPITAL   (Japan)

^g HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Acquired immunodeficiency syndrome; Chronic liver disease; Genotype; Interferon therapy

Indexed keywords

INTERFERON; PEGINTERFERON; RIBAVIRIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; BILIRUBIN BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENOTYPE; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JAPAN; LIVER CELL CARCINOMA; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; THROMBOCYTE COUNT; TREATMENT RESPONSE; VIRAL CONTAMINATION; VIRUS TRANSMISSION;

EID: 67649576954     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2009.00517.x     Document Type: Article

References (18)

1. Simon V, Ho DD, Karim QA. HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet 2006; 368: 489-504.
2. Schneider MF, Gange SJ, Williams CM et al. Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004. AIDS 2005; 19: 2009-18.
3. Kramer JR, Giordano TP, Souchek J, El-Serag HB Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era. J Hepatol 2005; 42: 309-14.
4. Merchante N, Giron-Gonzalez JA, Gonzalez-Serrano M et al. Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease. AIDS 2006; 20: 49-57.
5. Tatsunami S, Taki M, Shirahata A, Mimaya J, Yamada K. Increasing incidence of critical liver disease among causes of death in Japanese hemophiliacs with HIV-1. Acta Haematol 2004; 111: 181-4.
6. Shiffman ML. Optimizing the current therapy for chronic hepatitis C virus: Peginterferon and ribavirin dosing and the utility of growth factors. Clin Liver Dis 2008; 12: 487-505.
7. Lo Re V 3rd, Kostman JR, Amorosa VK. Management complexities of HIV/ hepatitis C virus coinfection in the twenty-first century. Clin Liver Dis 2008; 12: 587-609.
8. Koike K, Tsukada K, Yotsuyanagi H et al. Prevalence of coinfection with human immunodeficiency virus and hepatitis C virus in Japan. Hepatol Res 2007; 37: 2-5.
9. Okita K. Clinical aspects of hepatocellular carcinoma in Japan. Intern Med 2006; 45: 229-33.
10. Hayashi N, Takehara T. Antiviral therapy for chronic hepatitis C: Past, present, and future. J Gastroenterol 2006; 41: 17-27.
11. Yamaguchi T, Hashimoto S, Oka S et al. Physical condition and activity of daily living among HIV patients infected through blood products in Japan. J Epidemiol 2002; 12: 383-93.
12. Okanoue T, Itoh Y, Minami M et al. Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts. Hepatol Res 2008; 38: 27-36.
13. Benhamou Y, Bochet M, Di Martino V et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999; 30: 1054-8.
14. Bräu N, Fox RK, Xiao P et al. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A U.S.-Canadian multicenter study. J Hepatol 2007; 47: 527-37.
15. Shores NJ, Maida I, Soriano V, Nunez M. Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients. J Hepatol 2008; 49: 323-8.
16. Falconer K, Gonzalez VD, Reichard O, Sandberg JK, Alaeus A Spontaneous HCV clearance in HCV/HIV-1 coinfection associated with normalized CD4 counts, low level of chronic immune activation and high level of T cell function. J Clin Virol 2008; 41: 160-3.
17. Soriano V, Mocroft A, Rockstroh J et al. Spontaneous Viral Clearance, Viral Load, and Genotype Distribution of Hepatitis C Virus (HCV) in HIV-Infected Patients with Anti-HCV Antibodies in Europe. J Infect Dis 2008; 198: 1337-44.
18. Sugiyasu Y, Yuki N, Nagaoka T et al. Histological improvement of chronic liver disease after spontaneous serum hepatitis C virus clearance. J Med Virol 2003; 69: 41-9.